Protocol CE3005.

Study characteristics
Methods	RCT
Participants	Country: UK Enrolled 57 patients, stage IB or IIA Underwent primary surgery Assessed 54 (95%)
Interventions	Arm A: External beam pelvic radiotherapy (EBRT). Arm B: Adjuvant chemotherapy with bleomycin plus ifosfamide plus cisplatin plus external beam radiotherapy.
Outcomes	Survival, recurrence and toxicity.
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Not reported.
Allocation concealment (selection bias)	Unclear risk	Not reported.
Blinding (performance bias and detection bias) All outcomes	Unclear risk	Not reported.
Incomplete outcome data (attrition bias) All outcomes	Low risk	For all outcomes: % analysed: 54/57 (95%)
Selective reporting (reporting bias)	Unclear risk	Insufficient information to permit judgement.
Other bias	Unclear risk	Insufficient information to permit judgement.